Showing 1 - 6 results of 6 for search 'Olga Benitez Hidalgo', query time: 0.04s Refine Results
  1. 1
    Benefits of rIX-FP prophylaxis in patients with Haemophilia B: real-world evidence from a Spanish reference centre

    Benefits of rIX-FP prophylaxis in patients with Haemophilia B: real-world evidence from a Spanish reference centre by Olga Benítez-Hidalgo, Marc Bosch Schips, Juan Carlos Juárez Giménez, Mercedes Gironella

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management

    Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management by Olga Benitez Hidalgo, M. Fernanda Martinez Garcia, Agustin Bescos Cabestre, Juan Carlos Juarez Gimenez, Mercedes Gironella Mesa, Francesc Bosch Albareda

    Published 2022-05-01
    Get full text
    Article
  3. 3
    Portal vein thrombosis in a patient with severe hemophilia B: A challenging balanced management

    Portal vein thrombosis in a patient with severe hemophilia B: A challenging balanced management by Olga Benitez‐Hidalgo, Milagros Suito Alcántara, Maria Fernanda Martinez Garcia, Desiree Campoy, Pavel Olivera, Mercedes Gironella Mesa, Juan Carlos Juarez‐Gimenez

    Published 2024-02-01
    Get full text
    Article
  4. 4
    VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort

    VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort by Olga Benítez Hidalgo, Maria Fernanda Martinez Garcia, Irene Corrrales Insa, Mariana Fernández‐Caballero, Lorena Ramírez Orihuela, Vicente Cortina Giner, Natàlia Comes Fernández, Juan Carlos Juarez Gimenez

    Published 2023-05-01
    Get full text
    Article
  5. 5
    Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study

    Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study by Olga Benítez Hidalgo MD, Cristina Marzo Alonso MD, MSc, Francisco José López Jaime MD, Marina Carrasco MD, Maria del Mar Nieto Hernández MD, Natalia Afonso BPharm, Alejhandra Lei MD, Dermot Whyms MSc, Kim Hanna MSc, Maria Esperança Aragonés MSc, Mireia Torres MSc, Juan Oliveras PharmD

    Published 2025-03-01
    Get full text
    Article
  6. 6
    Clinical Efficacy and Safety of Fanhdi, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

    Clinical Efficacy and Safety of Fanhdi, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study by Víctor Jiménez-Yuste MD, PhD, María Teresa Alvarez-Román MD, Ángeles Palomo Bravo MD, Bernardo J. Galmes MD, Maria del Mar Nieto Hernández MD, Olga Benítez Hidalgo MD, Cristina Marzo Alonso MD, Noelia Florencia Pérez González MD, Julia Coll MD, Ramiro Núñez MD, Marina Carrasco MD, Faustino García Candel MD, Jose Ramon Gonzalez-Porras MD, Carmen Hernández García MD, Maria José Varó Castro MD, Roser Mir PhD

    Published 2022-02-01
    Get full text
    Article

Search Tools: